350 related articles for article (PubMed ID: 35338919)
21. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
[TBL] [Abstract][Full Text] [Related]
22. Strategies and challenges for non-viral delivery of non-coding RNAs to the heart.
Vilaça A; de Windt LJ; Fernandes H; Ferreira L
Trends Mol Med; 2023 Jan; 29(1):70-91. PubMed ID: 36371335
[TBL] [Abstract][Full Text] [Related]
23. The emerging roles of long noncoding RNAs in common cardiovascular diseases.
Jiang X; Ning Q
Hypertens Res; 2015 Jun; 38(6):375-9. PubMed ID: 25762413
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial noncoding RNA-regulatory network in cardiovascular disease.
Jusic A; Devaux Y;
Basic Res Cardiol; 2020 Mar; 115(3):23. PubMed ID: 32140778
[TBL] [Abstract][Full Text] [Related]
25. RNA (Epi)genetics in cardiovascular diseases.
Elia L; Condorelli G
J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNAs in cardiovascular diseases.
Uchida S; Dimmeler S
Circ Res; 2015 Feb; 116(4):737-50. PubMed ID: 25677520
[TBL] [Abstract][Full Text] [Related]
27. Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation, and Future Directions: A Scientific Statement From the American Heart Association.
Das S; Shah R; Dimmeler S; Freedman JE; Holley C; Lee JM; Moore K; Musunuru K; Wang DZ; Xiao J; Yin KJ;
Circ Genom Precis Med; 2020 Aug; 13(4):e000062. PubMed ID: 32812806
[TBL] [Abstract][Full Text] [Related]
28. The roles of long noncoding RNAs in myocardial pathophysiology.
Chen C; Tang Y; Sun H; Lin X; Jiang B
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694052
[TBL] [Abstract][Full Text] [Related]
29. Circulatory long noncoding RNAs (circulatory-LNC-RNAs) as novel biomarkers and therapeutic targets in cardiovascular diseases: Implications for cardiovascular diseases complications.
Emami Meybodi SM; Soleimani N; Yari A; Javadifar A; Tollabi M; Karimi B; Emami Meybodi M; Seyedhossaini S; Brouki Milan P; Dehghani Firoozabadi A
Int J Biol Macromol; 2023 Jan; 225():1049-1071. PubMed ID: 36414082
[TBL] [Abstract][Full Text] [Related]
30. Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.
Zhang C; Niu K; Lian P; Hu Y; Shuai Z; Gao S; Ge S; Xu T; Xiao Q; Chen Z
Hypertension; 2021 Jul; 78(1):16-29. PubMed ID: 34058852
[TBL] [Abstract][Full Text] [Related]
31. Noncoding RNAs in Muscle Atrophy.
Li Y; Meng X; Li G; Zhou Q; Xiao J
Adv Exp Med Biol; 2018; 1088():249-266. PubMed ID: 30390255
[TBL] [Abstract][Full Text] [Related]
32. The emerging role of noncoding RNAs in neuroinflammation: Implications in pathogenesis and therapeutic approaches.
Ebrahimi R; Golestani A
J Cell Physiol; 2022 Feb; 237(2):1206-1224. PubMed ID: 34724212
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic mechanisms underlying the benefits of flavonoids in cardiovascular health and diseases: are long non-coding RNAs rising stars?
Jiang Y; Sun-Waterhouse D; Chen Y; Li F; Li D
Crit Rev Food Sci Nutr; 2022; 62(14):3855-3872. PubMed ID: 33427492
[TBL] [Abstract][Full Text] [Related]
34. Circulating Non-coding RNAs and Cardiovascular Diseases.
Zhao C; Lv Y; Duan Y; Li G; Zhang Z
Adv Exp Med Biol; 2020; 1229():357-367. PubMed ID: 32285424
[TBL] [Abstract][Full Text] [Related]
35. Unlocking the dark matter: noncoding RNAs and RNA modifications in cardiac aging.
Kang J; Rhee J; Wang C; Yang Y; Li G; Li H
Am J Physiol Heart Circ Physiol; 2024 Mar; 326(3):H832-H844. PubMed ID: 38305752
[TBL] [Abstract][Full Text] [Related]
36. Noncoding RNAs: Versatile regulators of endothelial dysfunction.
Piao X; Ma L; Xu Q; Zhang X; Jin C
Life Sci; 2023 Dec; 334():122246. PubMed ID: 37931743
[TBL] [Abstract][Full Text] [Related]
37. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
Zhao G
J Med Genet; 2018 Nov; 55(11):713-720. PubMed ID: 30177556
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated micro-RNAs and long noncoding RNAs in cardiac development and pediatric heart failure.
Toni LS; Hailu F; Sucharov CC
Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1308-H1315. PubMed ID: 32216613
[TBL] [Abstract][Full Text] [Related]
39. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.
Bayoumi AS; Aonuma T; Teoh JP; Tang YL; Kim IM
Acta Pharmacol Sin; 2018 Jul; 39(7):1100-1109. PubMed ID: 29565037
[TBL] [Abstract][Full Text] [Related]
40. ncRNAs and polyphenols: new therapeutic strategies for hypertension.
Shirazi-Tehrani E; Chamasemani A; Firouzabadi N; Mousaei M
RNA Biol; 2022; 19(1):575-587. PubMed ID: 35438046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
